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Processing and secretion by Escherichia coli of a recombinant form of the 
immunogenic protein MPB70 of Mycobacterium bovis 
R. GLYN HEWINSON'* and WILLIAM P. RUSSELL~ 
Molecular Genetics Unit' and Applied and Molecular Immunology Unit2, Central Veterinary Laboratory, New Haw, 
Weybridge, Surrey KT15 3NB, UK 
(Received 16 November 1992; revised 25 January 1993; accepted 1 February 1993) 
The gene encoding an immunodominant secreted antigen, MPB70, of Mycobacterium bovis was cloned into the 
plasmid vector pBluescript I1 KS' along with its native ribosome-binding site. In this construct translation of the 
protein in Escherichia coli was from the native AUG initiation codon and was directed by the mycobacterial 
ribosome-binding site. Two different molecular mass forms (26 kDa and 22 kDa) of MPB70 were observed in 
whole-cell pellets of recombinant E. coli. The difference in size indicates cleavage of the signal peptide of MPB70 
by an endopeptidase of E. coli. MPB70 was secreted into the periplasm of recombinant E. coli, where the 22 kDa 
form of the protein was predominant. The culture filtrate contained only the 22 kDa form of the protein, which was 
soluble. The passage of MPB70 from the periplasm into the growth medium was found to be due, at least in part, 
to non-specific leakage of periplasmic proteins across the outer membrane associated with the expression of 
recombinant MPB70. 
Introduction 
Improvement of immunodiagnostic screening for Myco- 
bacterium bovis infection relies on the identification and 
purification of antigens exhibiting a high degree of 
specificity (Daniel & Janicki, 1978; Auer, 1987; Fifis et 
al., 1992). In order to identify such antigens for diagnosis 
in cattle, Fifis et al. (1992) purified a number of proteins 
from M. bovis and tested these antigens with panels of 
sera from M. bovis-infected cattle, M .  bovis culture- 
negative cattle, and cattle infected with other myco- 
bacteria. Their study identified a number of promising 
candidate antigens, of which the protein MPB70 gave 
greatest specificity for M. bovis infection. 
MPB70 is an immunodominant antigen of M. bovis 
(Fifis et al., 1989) containing M. bovis species-specific 
epitopes (Wood et al., 1988). The protein is an active 
component of bovine PPD (Harboe et al., 1990) and is 
able to elicit a delayed-type hypersensitivity (DTH) 
response (Nagai et al., 1981; Miura et aZ., 1983; Harboe 
et al., 1986; H a s h  et al., 1987), and to stimulate T 
lymphocyte proliferation (Fifis et al., 1989; Griffin et al., 
1991) and antibody production (Fifis et al., 1992; Wood 
et al., 1992) in M. bovis-infected animals. The protein is 
a major component of M. bovis culture filtrate (Nagai et 
al., 1981; Harboe et al., 1986; Abou-Zeid et al., 1987; 
*Author for correspondence. 
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Fifis et al., 1991) and is secreted from the cell following 
cleavage of a 30-amino-acid signal peptide which directs 
translocation of the hydrophobic molecule across the 
cytoplasmic membrane (Terasaka et al., 1989). MPB70 
has been cloned and sequenced (Terasaka et al., 1989; 
Radford et al., 1990). 
The use of isolated M. bovis antigens, such as MPB70, 
in immunodiagnostic assays is hindered by difficulties in 
growing the organism and purifying the antigens. 
Recombinant proteins may provide a realistic alterna- 
tive. Previous reports have indicated that bulk purific- 
ation of mycobacterial recombinant proteins in 
Escherichia coli may be achieved by fusion of the protein 
of interest to a second protein for which column 
purification procedures are available. However, this 
often results in the accumulation of the fusion protein as 
an insoluble protein mass within the bacterial cell 
(Vordermeier et al., 1991 ; Ashbridge et al., 1992), making 
purification difficult. 
This report describes the production of a plasmid 
construct which generates a form of MPB70 with 
retained antigenicity, that is secreted across the cyto- 
plasmic membrane of E. coli. The results indicate that the 
leader peptide of the recombinant mycobacterial protein 
is cleaved by an endopeptidase of E. coli, resulting in the 
accumulation of a soluble, mature form of the protein in 
the periplasm and growth medium, thus facilitating 
purification. 
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Methods 
Bacterial strains and vectors. Escherichia coli strain DH5a (F- 
480lacZAM15 A(lacZYA-argF)U169 recAl endA1 hsdRI7 (rk mi) 
supE44 2- thi-1 gyrA relAl) was used as host for plasmid vectors 
pBluescript I1 KSf (Stratagene), pUC18 and pUC19 (Gibco-BRL). 
The M.  bovis DNA used in this study was extracted from strain AN5 
(Central Veterinary Laboratory, Weybridge, UK). 
Immunological reagents. M .  bovis sonicated extract was prepared by 
the method of Morris et al. (1985). Rabbits were immunized 
subcutaneously at multiple sites with M.  bovis sonicated extract 
(100 pg) in Freund's incomplete adjuvant. The rabbits were boosted 
twice at 14 d intervals. Murine anti-MPB70 monoclonal antibody, 
SBlO (Wood et al., 1988), was purchased from Agen Biomedical 
(Queensland, Australia). Rabbit antibody directed against p-lactamase 
of E. coli was purchased from CP Laboratories (Hertfordshire, UK). 
Polymerase chain reaction (PCR). DNA was extracted from M .  bovis 
strain AN5 by the method of Whipple et al. (1987). PCR was 
performed in 50 p1 reaction mixtures containing 50 mM-KC1, 10 mM- 
Tris/HC1 (pH 84), 0.01 YO (w/v) gelatin, 3 mM-MgCl,, 200 p~ of each 
dinucleotide triphosphate (dNTP), 2-5 U of thermostable Taq DNA 
polymerase (Perkin-Elmer Cetus) and 20 pmol of each oligonucleotide 
primer. The DNA sequence of the primers was as follows: 5'- 
AAAGAATTCGGACGGCTCCGAAGAAATC-3' and 5'- 
CCCGGATCCTTACGCCGGAGGCATTAGCAC-3'. The reaction 
mixture was overlaid with 50 pl mineral oil and DNA samples (10 ng) 
were pipetted through the oil into the mixture. The parameters for 
amplification were: denaturation at 94 "C for 3 min for one cycle, 
followed by 30 cycles at 94 "C for 1.5 min, 56 "C for 1.5 rnin and 72 "C 
for 2 min. A final extension at 72 "C for 10 rnin was also included. A 
reagent blank (negative control) was as described above but without 
the addition of DNA sample. 
Sequence analysis. DNA sequencing of double-stranded template 
was performed using the primer-extension dideoxy chain-termination 
method (Sanger et al., 1977) as recommended by the manufacturer 
(Sequenase, United States Biochemicals). 
Other genetic procedures. Restriction endonucleases and other 
enzymes were used according to the manufacturers' instructions. Other 
genetic manipulations were as described by Sambrook et al. (1989). 
Osmotic shock procedure. The method used to obtain periplasmic and 
cytoplasmic cell fractions was a modification of that described by 
Koshland & Botstein (1980). A 10 ml overnight culture of bacterial 
cells was grown in Luria-Bertani broth, with 0.1 % (w/v) glucose added 
(LBG; Sambrook et al., 1989), in the presence of 1OOpg ampicillin 
ml-'. The culture was harvested by centrifugation at 5000 g, 15 min, 
20 "C. The supernatant was discarded and the cells washed twice in 
40 ml LBG broth. The final pellet was resuspended in 10 ml LBG broth 
and 1 ml was inoculated into 100 ml LBG broth with 50 pg ampicillin 
ml-' in a 250 ml conical flask. The cells were incubated at  37 "C, 
200 r.p.m. for 2 4  h until an OD550 of 0-5-0-7 was obtained (i.e. 
exponential-phase growth). 
The OD,,, of the cells was standardized to 0.5 by dilution in LBG 
broth. The cell suspension (50 ml) was harvested by centrifugation; the 
supernatant was removed and filtered twice through 0.2 pm filters. The 
filtrate was concentrated to 0.09 volumes (Le. 1 l-fold concentration) by 
ultrafiltration (Centricon, Amicon) and saved as the culture filtrate 
fraction. The cell pellet was resuspended in 4.5 ml ice-cold 20 % (w/v) 
sucrose, 10 mM-Tris/HCl (pH 7.5). EDTA solution (05 M, pH 8, 
150 pl) was added and incubation was continued on ice for 10 min. All 
subsequent steps were carried out at 4 "C. A sample (1.5 ml) was 
removed for use as the untreated control. The remaining cell suspension 
was dispensed in 1.5 ml volumes into Eppendorf tubes and centrifuged 
for 5 min at 13000 g, 4 "C. The supernatant fluid was removed quickly 
and the pellet rapidly resuspended by vigorous agitation in 1 ml ice- 
cold distilled water. The mixture was incubated for 10 rnin on ice and 
then centrifuged for 10 rnin at 13000 g, 4 "C. The supernatant fluid was 
recovered (periplasmic fraction). Residual fluid was removed carefully 
from the cells and the remaining cell pellet was resuspended in 1 ml 
distilled water (the cytoplasmic fraction). All cellular fractions were 
stored at -20 "C prior to use. 
Determination of p-lactarnase activities. The hydrolysis of the 
chromogenic cephalosporin nitrocefin (O'Callaghan et al., 1972) by j3- 
lactamase at 37 "C was monitored at 550 nm (Angus et al., 1982). The 
molar absorption coefficient for nitrocefin was 10.7 1 mmol-' cm-'. The 
reaction mixture (final volume 1 ml) contained 5 m~-MgC1,/25 mM- 
MOPS (pH 7.4) and 13-126 pwnitrocefin. The reaction was started by 
the addition of 10 p1 of osmotic shock fraction. Initial rates of 
nitrocefin hydrolysis by the p-lactamase present in each osmotic shock 
fraction were determined by the chord-drawing method of Waley 
(1981). Values for X, and V,,, of the p-lactamase in each osmotic 
shock preparation were determined using linear regression analysis of 
Lineweaver-Burk plots. From these, a mean value of the K ,  for 
nitrocefin hydrolysis by the p-lactamase encoded by pBluescript I1 KS+ 
was obtained. To enable direct comparison of V,,, for all experiments, 
the mean of the K, values was used to calculate V,, from initial rates 
of nitrocefin hydrolysis using the Michaelis-Menten equation. 
SDS-PAGE. Protein samples (50 pl) were solubilized by heating at 
100 "C for 3min in 50p1 sample loading buffer [75mM-Tris/HC1, 
pH 6.8, 5 YO (v/v) 2-mercaptoethanol, 2 YO (w/v) sodium dodecyl 
sulphate, 10 YO (v/v) glycerol, 0.002 YO (w/v) bromophenol blue]. 
Fractions were then separated on a 12.5 YO (w/v) SDS-polyacrylamide 
gel using a discontinuous Tris/HCl buffer system as described by 
Laemmli (1 970). Rainbow protein markers (Amersham) were run as 
molecular mass standards. 
Immunoblotting. Proteins were transferred to nitrocellulose by 
electroblotting as described by Matsudaira (1 987). Membranes were 
blocked with 3% (w/v) bovine serum albumin (BSA) in phosphate- 
buffered saline (PBS) for 30 min, washed in PBS with 0.05 YO (w/v) 
Tween 20 (PBST) and incubated for 1 h with rabbit antiserum directed 
against sonicated M .  bovis (diluted 1 in 500 in PBST), or with rabbit 
antiserum directed against p-lactamase (diluted 1 in 500 in PBST). 
Membranes were washed and incubated for 30min at 20°C with 
alkaline-phosphatase-conjugated anti-rabbit immunoglobulin (Sigma ; 
diluted 1 in 8000 in PBST). After washing, bound alkaline phosphatase 
was detected using Nitro Blue Tetrazolium as described by Blake et al. 
(1984). 
Cloning of the gene encoding MPB70 and its expression 
in E. coli 
PCR was used to amplify the gene encoding MPB70 
from chromosomal DNA extracted from M. bovis AN5. 
The oligonucleotide primers used in this reaction were 
designed to give a product of 678 bp encompassing 
660 bp of mycobacterial DNA encoding the MPB70 
structural gene with an additional 78 bp upstream of the 
AUG initiation codon and restriction endonuclease sites 
at each end to allow cloning into the plasmid vector. The 
upstream region of DNA included a putative ribosome- 
binding site at positions - 13 to -9 from the initiation 
codon (Terasaka et al., 1989; Radford et al., 1990). Thus 
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Fig. 1. Western blots of recombinant E. coli clones incubated with 
polyclonal antisera directed against sonicated M .  bovis. pBluescript I1 
KS' is the original plasmid vector. Plasmid pVW500 was constructed 
by cloning the gene encoding MPB70 into pBluescript I1 KS+ as 
described in Results. Lanes: 1, E.  coli DHScr(pB1uescript I1 K S )  
culture filtrate; 2, E. coli DH5a(pBluescript I1 K S )  cell pellet; 3, E. coli 
DHSa(pVW5OO) culture filtrate; 4, E. coli DHSa(pVW5OO) cell pellet. 
Arrowheads indicate the positions of the two forms of MPB70. 
it was envisaged that by cloning the PCR product into 
the vector pBluescript I1 KS+ transcription of the gene 
encoding MPB70 would occur from the lac2 promoter 
of the vector and that translation of MPB70 would occur 
from ribosomes binding to the cloned ribosome-binding 
site. A 678 bp product was obtained from the PCR and 
was ligated into pBluescript I1 KS+ using the EcoRI and 
BamHI restriction endonuclease sites encoded by the 
oligonucleotide primers. The recombinant plasmid was 
transformed into E. coli DH5a. The identity of the 
mycobacterial insert in E, coli transformed with the 
recombinant plasmid was confirmed by DNA sequence 
analysis. The recombinant plasmid was designated 
Expression of MPB70 was detected by Western 
blotting using polyclonal rabbit antisera directed against 
sonicated M .  bovis. Two forms of MPB70 were observed 
in the cell pellet (Fig. 1, lane 4). These polypeptides were 
not detected in the cell pellet of control recombinant E.  
coli containing plasmid without the mycobacterial DNA 
insert (Fig. 1, lane 2). One form of MPB70 gave an 
apparent molecular mass of 26 kDa, the other, pre- 
dominant form, gave an apparent molecular mass of 
22 kDa as estimated by denaturing PAGE. The ex- 
pression of MPB7O was confirmed by Western blot 
analysis of the recombinant proteins using SB10, a 
monoclonal antibody specific for MPB70 (Wood et al., 
1988). SBlO bound both forms of recombinant MPB70, 
although its affinity for the polypeptides was not as high 
as that of the polyclonal antisera (data not shown). 
In order to determine whether transcription of MPB70 
was from a promoter present in the 78 bp of M .  bovis 
pvw500. 
DNA upstream of the MPB70 initiation codon or from 
the lac2 promoter of the plasmid vector, the entire DNA 
fragment was excised from pVW500 using EcoRI and 
BamHI endonuclease digestion and ligated into the 
plasmid vectors pUC18 and pUC19. This procedure 
introduced the DNA fragment into pUC in both 
orientations relative to the lacZ promoter. Western blot 
analysis using the rabbit antisera raised against sonicated 
M.  bovis showed that MPB70 was only expressed by 
recombinant E. coli containing the pUC18 construct, i.e. 
in the same orientation as pVW500, suggesting that 
expression was under control of the lac2 promoter. 
Secretion of MPB70 by E. coli 
Western blotting of concentrated culture filtrate using 
rabbit antisera raised against sonicated M.  bovis detected 
the presence of only the 22 kDa form of recombinant 
MPB70 in the culture medium (Fig. 1, lane 3). This 
suggested that MPB70 was expressed and secreted by E. 
coli via a mechanism involving cleavage of the secretory 
signal peptide. In order to confirm this, osmotic shock 
was used to obtain cytoplasmic and periplasmic fractions 
of the recombinant cells. These fractions, and the culture 
filtrates from recombinant E. coli, with and without the 
MPB70 DNA insert, were Western blotted with antisera 
directed against sonicated M .  bovis (Fig. 2a). The 
majority of the 26 kDa form of MPB70 was restricted to 
the cytoplasmic fraction of recombinant E. coli (lane 3), 
whereas the 22 kDa form was detected in the culture 
filtrate, the cytoplasm and the periplasm (lanes 1-3). 
The cellular fractions were also analysed for the 
presence of p-lactamase (a periplasmic protein of 29 kDa 
that is synthesized as a preprotein with a typical signal 
peptide of 23 amino acids: Sutcliffe, 1978; Koshland & 
Botstein, 1980), which was encoded by the plasmid 
vector. P-Lactamase was detected by Western blotting 
using specific rabbit antisera (Fig. 2b). A similar pattern 
of P-lactamase secretion to that of MPB70 was observed. 
Two forms of P-lactamase (of approximately 31.5 kDa 
and 29 kDa) were detected in the cytoplasm and 
periplasm (lanes 2, 3, 5 and 6), although the lower 
molecular mass form was predominant in the periplasm 
(lanes 2 and 5). The lower molecular mass form was also 
observed in the culture filtrate (lanes 1 and 4), suggesting 
some leakage across the outer membrane. 
Measurement of p-lactamase leakage across the outer 
membrane of recombinant E. coli 
In order to establish whether the presence of MPB70 in 
the culture filtrate was due to active secretion via a 
specific pathway, or to a general increase in the leakage 
of proteins through the outer membrane, the p-lactamase 
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Fig. 2. (a) Western blots of cellular fractions of recombinant E. coli clones incubated with polyclonal sera raised against sonicated M.  
bovis. Plasmid pBluescript I1 KS' is the original plasmid vector. Plasmid pVW500 was constructed by cloning the gene encoding MPB70 
into pBluescript I1 KS' as described in Results. Lanes: 1, E. coli DH5cr(pVW500) culture filtrate; 2, E. coli DHScr(pVWSO0) periplasmic 
fraction; 3 ,  E. coli DHScr(pVW5OO) cytoplasmic fraction; 4, E. coli DHScr(pB1uescript I1 KS+) culture filtrate; 5, E. coli 
DHSa(pB1uescript I1 KS+) periplasmic fraction; 6, E. coli DHSa(pB1uescript I1 KS') cytoplasmic fraction. Arrowheads indicate the 
positions of the two forms of MPB70. (b) Western blots of cellular fractions of recombinant E. coli clones incubated with polyclonal 
sera raised against P-lactamase. Lanes 1 to 6 as for (a). Arrowheads indicate the positions of the two forms of p-lactamase. 
Table 1. P-Lactamase activities of cellular fractions of recombinant E. coli 
Bacteria were grown to early exponential phase growth in LBG broth. The cells were harvested 
and the cellular fractions obtained by osmotic shock treatment. Hydrolysis of nitrocefin was 
monitored spectrophotometrically (550 nm) at  37 "C in 5 m~-MgC1,/25 mM-MOPS (pH 7.4). 
Initial rates of hydrolysis were determined by the chord-drawing method of Waley (198 1) and 
were used to calculate K,,, and V, using Lineweaver-Burk plots. A mean I&, value of 
35.7 8.4 p~ (n  = 10) was obtained. This value was used to calculate V,, [nmol min-* (mg dry 
mass)-'] from each initial rate of hydrolysis using the Michaelis-Menten equation. The SEM was 
calculated from the values obtained using either 27 (*) or 12 (7) initial rates of nitrocefin 
hydrolysis in the concentration range 10-120 pmnitrocefin from three separate experiments. 
Plasmid in Vmax Vmax Vmax Vma, culture filtrate/ 
E. coli DH5a culture filtrate periplasmic cytoplasmic Vmax periplasmic 
pBluescript I1 KS' 1017 (t-424*) 3111 (f184*) 178 (k477) 0.33 
pVW.500 2785 (&808*) 1656('274*) 164(*127?) 1-68 
activity was measured in each of the cellular fractions. 
The results of three experiments comparing the p- 
lactamase activities in the cellular fractions of re- 
1017f424 nmol min-' (mg dry mass)-'; n = 271. The 
ratio Vmax culture filtrate/Vmax periplasm was 1.68 for E. 
coli expressing MPB70 whereas for cells not expressing 
combinant E. coli expressing MPB70 and E. coli MPB70 it was only 0.33. 
containing plasmid without the MPB70 insert are shown 
in Table 1. The p-lactamase activities in the culture 
filtrate were consistently higher for E. coli expressing 
MPB70 [ Vmax = 2785 808 nmol min-' (mg dry mass)-' ; 
meanksm,  n = 271 than the activities observed for 
recombinant E. coli that did not express MPB70 [ Vmax = 
Discussion 
The intention of this study was to 
antigens for the development of 
blood-based immunodiagnostic 
produce recombinant 
sensitive and specific 
tests of M .  bovis 
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infections in domestic and wild animals. Antigen pro- 
duction in E. coli rather than in M .  bovis reduces the 
problems associated with the slow generation time of M .  
bovis, the infectivity of the pathogen and the more 
complex biochemical composition of mycobacteria. The 
immunogenic protein MPB70 is a suitable candidate 
antigen for diagnosis since it has been shown to be the 
most specific antigen for serodiagnosis of M .  bovis 
infection in cattle (Fifis et al., 1992). Fortuitously, the 
recombinant MPB70 produced in this study was found 
to be secreted across the cytoplasmic membrane of E. coli 
and to accumulate in the periplasm and culture medium 
of the organism. 
Since the plasmid construct encoding MPB70 
(pVW500) also contained 81 bp of mycobacterial DNA 
upstream from the initiation codon, it was possible that 
transcription of MPB70 was initiated from a myco- 
bacterial promoter present in this DNA fragment. 
However, as expression was only observed in one 
orientation of the mycobacterial DNA insert relative to 
the lac2 promoter, we conclude that it is most likely that 
transcription is directed from the lac2 promoter of the 
plasmid vector. This result is consistent with the 
sequencing data of Terasaka et al. (1989), which 
identified putative promoter sequences at positions - 148 
to - 143 and - 124 to - 119 upstream of the MPB70 
initiation codon (i.e. outside the DNA region contained 
in pVW500). Moreover, insertion of the PCR product 
into the lac2 gene of pBluescript I1 KS+ and pUC18 
introduced a stop codon in the lacZ gene at positions - 8 
to - 6 from the initiation codon of the MPB70 structural 
gene, thus creating a two-cistron expression system 
(Schoner et al., 1984). It therefore seems likely that 
expression of MPB70 was achieved by translational 
coupling (Schoner et al., 1984). In this system it is 
envisaged that transcription is initiated from the lacZ 
promoter, the E. coli ribosomes bind the putative 
ribosome-binding site (Terasaka et al., 1989; Radford et 
al., 1990) encoded by the M .  bovis DNA insert and 
MPB70 is translated from its native AUG initiation 
codon. In some cases this type of two-cistron con- 
struction has been shown to improve the efficiency of 
translation of heterologous genes in E. coli (Schoner et 
al., 1984). 
Two forms (26 kDa and 22 kDa) of the recombinant 
MPB70 were produced by E. coli containing the plasmid 
construct pVW500. Analysis of the protein sequence of 
MPB70 reveals the presence of a 30-amino-acid secretory 
signal sequence at the amino-terminus of the protein 
(Terasaka et al., 1989; Radford et al., 1990). This is 
cleaved from the mature protein during secretion by M .  
bovis (Radford et al., 1990). The signal peptide of MPB70 
conforms to the physico-chemical properties observed 
for other bacterial signal peptides (Von Heijne, 1988) in 
that the peptide has a positively charged amino-terminal 
region, a central hydrophobic region and a more polar 
carboxy-terminal with an Ala-X-Ala endopeptidase 
recognition site. The difference in molecular mass of the 
two forms of MPB70 can therefore be explained by 
cleavage of the 30-amino-acid secretory signal peptide 
(Terasaka et al., 1989; Radford et al., 1990) from the 
26 kDa form of MPB70 by an endopeptidase of E. coli. 
The molecular mass of mature MPB70 predicted from 
the amino acid sequence is 16-3 kDa (Terasaka et al., 
1989; Radford et al., 1990) rather than the observed 
22 kDa. However, mature native MPB70 from M .  bovis 
also displays aberrant mobility in denaturing PAGE, 
giving an apparent molecular mass of 18-23 kDa (Miura 
et al., 1983; Nagai et al., 1986; Abou-Zeid et al., 1987; 
Haslrav et al., 1987; Fifis et al., 1989). Therefore, when 
the signal peptide is removed, both native and re- 
combinant MPB70 display similar aberrant mobilities. 
Preliminary unpublished data suggest that the PI of the 
recombinant form of MPB70 (4.8) is similar to the value 
of 4.5-5.0 reported for native MPB70 (Nagai et al., 1986; 
Fifis et al., 1989). 
Secretion of recombinant MPB70 into the periplasm 
of E. coli was observed. To our knowledge this is the first 
report of the secretion of a mycobacterial protein by a 
Gram-negative bacterium. Moreover, the 22 kDa form 
of MPB70 was detected in both the periplasm and 
culture filtrate of recombinant E. coli in the exponential 
phase of growth. Since the signal peptide of MPB70 was 
removed following translocation across the cytoplasmic 
membrane, it seemed likely that the appearance of 
MPB70 in the culture medium was either due to non- 
specific leakage across the outer membrane or to a 
specific, signal-peptide-independent process. Recent 
studies indicate that several pathways exist for the 
secretion of proteins across the outer membrane 
(Pugsley, 1989). However, our results show that the 
expression of MPB70 in E. coli gives rise to an increase 
in leakage of the normally periplasmic P-lactamase 
across the outer membrane into the culture medium. 
Therefore the accumulation of recombinant MPB70 in 
the culture medium of E. coli is due, at least in part, to 
non-specific leakage of periplasmic proteins across the 
outer membrane. A likely explanation for this leakage is 
that hydrophobic interactions between the outer mem- 
brane and MPB70, which is a hydrophobic molecule 
(Terasaka et al., 1989), cause some disruption of the outer 
membrane. However, expression of MPB70 did not 
affect the growth rate of the cells in culture (unpublished 
data). 
This processing and secretion of the mycobacterial 
antigen MPB70 by E. coli may be exploited for the 
purpose of antigen production. Production of MPB70 in 
this way has several advantages. Secretion precludes 
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proteolysis of the protein by housekeeping cytoplasmic 
peptidases, which would normally remove abnormal 
proteins from the cytoplasm, and separates it from 
contaminating cytoplasmic proteins. Moreover, proces- 
sing of the protein by E. coli results in the production of 
a mature, soluble form of MPB7O which resembles the 
native molecule, whereas recombinant proteins are often 
produced as chimeric fusion proteins which might alter 
the conformation of the protein. 
The ability of E. coli to secrete MPB70 raises the 
possibility that E. coli and attenuated oral vaccine strains 
of salmonella might be able to secrete a range of 
mycobacterial antigens. This possibility is currently 
under investigation. 
We are most grateful to Dr M. J. Woodward and Dr D. G. Newel1 
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